Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.
On this week’s podcast we highlight US Medicare reimbursement topics that industry should keep an eye on, and discuss important regulatory changes underway in the UK.
In this edition of Device Week, Medtech Insight’s Marion Webb reviews the huge number of digital health investments announced in 2021, including numerous SPAC deals. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics.
In this week’s podcast, EU regulatory editor Amanda Maxwell walks us through the latest news and documents coming out of the European Union’s efforts to revamp its medical device and diagnostics rules and makes some predictions about what we can expect to see going forward.
MHRA Must Seize UK Digital And Diagnostics Opportunity: ABHI Perspectives On Enabling Regulation – Part 2
IVD and healthtech industry representatives give their views on how the future UK medtech system can be shaped to be agile and responsive to patients’ needs, mindful that the regulator must deliver a standalone regulatory system and functional UKCA marking in less than two years.
In this week’s podcast, Medtech Insight editors Marion Webb and Reed Miller discuss the latest news from the American Diabetes Association conference as well as an interview with Dexcom CEO Kevin Sayer about the company’s strategy in the blood glucose measurement market.
In this week’s podcast, senior reporter Ferdous Al-Faruque discusses the most interesting tidbits about staff burnout, MDUFA negotiations and more from his recent interview with US FDA device center chief Jeff Shuren, and managing editor Elizabeth Orr offers updates on what two recent Supreme Court patent decisions could mean for medtech.
A Chat With Jeff Shuren: FDA Device Center Chief Worries About Agency Staffing; Talks MDUFA V, Pandemic, More
The head of the US agency’s device center spoke with Medtech Insight in an exclusive wide-ranging interview about his priorities for the future, the nuances of the MDUFA V user-fee negotiations, how COVID-19 has changed the agency, and more.
In this edition of Device Week, Medtech Insight's UK-based reporter Barnaby Pickering provides an insight into Procyrion’s novel device for decongesting cardiorenal syndrome patients. US Commercial and R&D manager, Reed Miller, highlights details on Pear Therapeutics’ recent SPAC acquisition, and managing editor, Marion Webb, discusses two companies that received types of approval for novel devices.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.